Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer

Table 1

The relationship between serum tumor marker levels and clinicopathological features in patients with IBD and rectal cancer ().

Clinicopathological features		CA242 (U/ml)			CA724 (U/ml)			TPA (U/L)
Gender			0.738	0.463		0.607	0.546		1.206	0.233
Male	36
Female	24
Age (years old)			1.081	0.284		0.530	0.598		0.910	0.367
≥50 years old	34
<50 years old	26
Tumor size (cm)			11.888	<0.001		0.786	0.435		0.577	0.566
≥5	32
<5	28
Histological grades			3.146	0.012		6.223	0.012		2.653	0.023
G1	15
G2	40
G3	5
Growth modes			13.029	<0.001		5.157	0.040		2.660	0.096
Ulcerative	30
Invasive	25
Contracted	5
T stages			3.532	0.001		10.081	<0.001		4.392	<0.001
	20
	40
N stages			0.783	0.437		8.461	<0.001		0.955	0.344
	32
	28
M stages			1.208	0.232		8.866	<0.001		3.048	0.004
	52
	8
TNM stages			3.901	<0.001		9.669	<0.001			<0.001
I-II	30
III-IV	30
Perineural invasion			0.153	0.879		0.687	0.495		0.601	0.550
	5
	55
Vascular invasion			0.287	0.775		1.426	0.159		0.477	0.656
	6
	54